Aug 2 (Reuters) – UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Yordan Alvarez's 4-hit game powers surging Astros past Rangers
Yordan Alvarez capped his second four-hit game of the season with a two-out, two-run double…
Japan to vow coordination with US on weak yen in historic battle
By Makiko Yamazaki and Leika Kihara TOKYO, Aug 3 (Reuters) - Japan is expected to…
UPDATE 1-Death toll from migrant rush into Spanish enclave in North Africa rises to 72
(Updates with Moroccan statement in paragraphs 1, 6-9) * Five more bodies recovered along Ceuta…
